The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
12 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,528,091 in first-year total cost, median $407,387.
Most frequent study sections
- Special Emphasis Panel[ZRG1 IFCN-Z (56)]6
- Special Emphasis Panel[ZRG1 IFCN-C (56)]3
- Special Emphasis Panel[ZRG1 IFCN-L (56)]1
- Special Emphasis Panel[ZRG1 IFCN-N (56)]1
- Special Emphasis Panel[ZRG1 IFCN-Z (55)]1
Most frequent institutions
- TEMPLE UNIV OF THE COMMONWEALTH2
- UNIV OF ARKANSAS FOR MED SCIS2
- ARIZONA STATE UNIVERSITY-TEMPE CAMPUS1
- MCLEAN HOSPITAL1
- NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Behavioral Pharmacology of Synthetic Cannabinoids1R01DA043700-01A1 | PARONIS, CAROL A | MCLEAN HOSPITAL, MA | $583,294 | ZRG1 |
| 2018 | Chemokine CXCL12/CXCR4 system and synthetic cathinones1R01DA045499-01A1 | RAWLS, SCOTT M.UNTERWALD, ELLEN M | TEMPLE UNIV OF THE COMMONWEALTH, PA | $381,649 | ZRG1 |
| 2017 | Characterization and reversal of neurocognitive dysfunction produced by long-term synthetic cathinone use1R01DA043172-01A1 | OLIVE, M. FOSTER | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS, AZ | $379,952 | ZRG1 |
| 2017 | The Next Generation of Hallucinogens: A New Class of Synthetic Psychoactive Drugs1R01DA041336-01A1 | HALBERSTADT, ADAM L. | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $339,221 | ZRG1 |
| 2016 | Synthetic Cannabinoid Toxicity: Role of Biotransformation1R01DA039143-01A1 | PRATHER, PAUL L | UNIV OF ARKANSAS FOR MED SCIS, AR | $549,674 | ZRG1 |
| 2016 | Investigation of Synthetic Cannabinoid Exposures and Pharmacological Consequences1R01DA040460-01A1 | THOMAS, BRIAN F | RESEARCH TRIANGLE INSTITUTE, NC | $458,126 | ZRG1 |
| 2016 | Dissecting the Abuse Liability of Synthetic Cathinone Stimulants1R01DA042211-01 | DICKERSON, TOBIN JTAFFE, MICHAEL A. | SCRIPPS RESEARCH INSTITUTE, THE, CA | $433,125 | ZRG1 |
| 2016 | Neurochemical and Behavioral Effects of Synthetic Cathinones1R01DA039145-01A1 | FLECKENSTEIN, ANNETTE | UNIVERSITY OF UTAH, UT | $335,250 | ZRG1 |
| 2015 | Preclinical Synthetic Cannabinoid Vapor Inhalation: Acute and Chronic Effects1R01DA039123-01 | COOPER, ZIVA DFOLTIN, RICHARD W | NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC, NY | $708,676 | ZRG1 |
| 2015 | Pharmacology and Therapy for MDPV and alpha-PVP Like Drugs of Abuse1R01DA039195-01 | OWENS, SAMUEL MICHAEL | UNIV OF ARKANSAS FOR MED SCIS, AR | $679,014 | ZRG1 |
| 2015 | Psychoactive bath salts and the glutamate system1R01DA039139-01 | RAWLS, SCOTT M. | TEMPLE UNIV OF THE COMMONWEALTH, PA | $369,778 | ZRG1 |
| 2015 | Bath salts: abuse-related and toxic effects1R01DA039146-01 | COLLINS, GREGORY THOMAS | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | $310,332 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.